HI HB 553
died on adjournmentRELATING TO INSURANCE.
Hawaii · 2026 Regular Session · lower
Quick answers
Did HI HB 553 pass?
No. HI HB 553 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-12-08): Carried over to 2026 Regular Session.
What is HI HB 553 about?
Beginning 1/1/2026, requires health insurers, mutual benefit societies, health maintenance organizations, and health plans under the State's Medicaid managed care program to provide coverage for biomarker testing. Effective 7/1/3000. (HD1)
Who sponsors HI HB 553?
OLDS, TAKAYAMA, POEPOE and 12 others are the primary sponsors of HI HB 553.
Description
Beginning 1/1/2026, requires health insurers, mutual benefit societies, health maintenance organizations, and health plans under the State's Medicaid managed care program to provide coverage for biomarker testing. Effective 7/1/3000. (HD1)
- Introduced
- 2025-01-21
- Latest action
- 2025-12-08 — Carried over to 2026 Regular Session.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- OLDSprimary
- TAKAYAMAprimary
- POEPOEprimary
- SAYAMAprimary
- PERRUSOprimary
- CHUNprimary
- AMATOprimary
- GRANDINETTIprimary
- HUSSEYprimary
- IWAMOTOprimary
- LAMOSAOprimary
- LOWENprimary
- MARTENprimary
- MIYAKEprimary
- TAKENOUCHIprimary
Committees
Not provided by source.
Action timeline
2025-12-08
Carried over to 2026 Regular Session.
carried-over
2025-02-11
The committee(s) on CPC recommend(s) that the measure be deferred.
deferral
2025-02-07
Bill scheduled to be heard by CPC on Tuesday, 02-11-25 2:00PM in House conference room 329 VIA VIDEOCONFERENCE.
2025-02-06
Passed Second Reading as amended in HD 1 and referred to the committee(s) on CPC with Representative(s) Belatti voting aye with reservations; none voting no (0) and Representative(s) Ward excused (1).
reading-2,referral-committee
2025-02-06
Reported from HLT/HSH (Stand. Com. Rep. No. 185) as amended in HD 1, recommending passage on Second Reading and referral to CPC.
2025-01-31
The committee on HSH recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 9 Ayes: Representative(s) Marten, Olds, Amato, Chun, Keohokapu-Lee Loy, Takayama, Takenouchi, Alcos, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.
committee-passage-favorable
2025-01-31
The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 9 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Chun, Marten, Olds, Takenouchi, Alcos, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.
committee-passage-favorable
2025-01-28
Bill scheduled to be heard by HLT/HSH on Friday, 01-31-25 9:00AM in House conference room 329 VIA VIDEOCONFERENCE.
2025-01-21
Referred to HLT/HSH, CPC, FIN, referral sheet 2
referral-committee
2025-01-21
Introduced and Pass First Reading.
introduction,reading-1
2025-01-17
Pending introduction.
Versions
Documents
Votes
The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS.
2025-01-31 · pass · 9-0
Member-level votes (9)
- Takayama: yes
- Keohokapu-Lee Loy: yes
- Amato: yes
- Chun: yes
- Marten: yes
- Olds: yes
- Takenouchi: yes
- Alcos: yes
- Garcia: yes
The committee on HSH recommend that the measure be PASSED, WITH AMENDMENTS.
2025-01-31 · pass · 9-0
Member-level votes (9)
- Marten: yes
- Olds: yes
- Amato: yes
- Chun: yes
- Keohokapu-Lee Loy: yes
- Takayama: yes
- Takenouchi: yes
- Alcos: yes
- Garcia: yes
Related bills
- Companion bill: SB 969
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:20:09.051962Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=HI&identifier=HB 553. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.